BAK, BRBRKMACNPA4

Creditors seek USD 3 billion and Braskem stock gains 7.25 percent

Published on 10/05/2026 at 17:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Braskem reported USD 1.04 billion in recurring operating earnings for the second quarter of 2026. Braskem stock costs EUR 0.74 on October 5, 2026 after EUR 0.69, plus 7.25 percent.

BAK, BRBRKMACNPA4, Illustration mit AI erstellt.
BAK, BRBRKMACNPA4, Illustration mit AI erstellt.

Braskem (ISIN BRBRKMACNPA4) stock was trading at EUR 0.74 at Lang & Schwarz on October 5, 2026 at 5:39 p.m. CEST, after the Xetra close, up 7.25 percent versus the Lang & Schwarz prior close of EUR 0.69 dated October 2, 2026. Creditors are demanding USD 3.00 billion in fresh capital from Braskem's controlling holders, according to Bloomberg on September 21, 2026.

USD 3 billion capital demand

The request comes as Braskem works through a restructuring involving USD 11.00 billion of debt. The creditors want the controlling shareholders to provide the new equity, while the restructuring talks have become the central issue for the company.

Rio Times reported on September 22, 2026 that creditors had set October 9, 2026 as a marker for a deal, while the broader protection window runs to November 22, 2026. The dates turn the capital request into a near-term financing test rather than a distant balance-sheet concern.

Q2 earnings mask restructuring risk

Braskem reported recurring EBITDA of USD 1.04 billion for the second quarter of 2026, with a 24.00 percent margin, according to ScanX on September 18, 2026. Brazil segment recurring EBITDA rose 261.00 percent quarter over quarter to USD 869.00 million, showing how wider spreads and tax credits lifted reported profitability.

The same results also show why operating improvement does not settle the financing question. Mexico polyethylene utilization fell to 43.00 percent, while a USD 115.00 million PIS/COFINS credit supported the quarter, leaving earnings exposed to spread normalization and non-operating effects.

HSBC cuts target to USD 1.50

HSBC downgraded Braskem from buy to hold and cut its price target from USD 6.50 to USD 1.50, Investing.com reported on September 28, 2026. The report linked the downgrade to higher equity risks during the debt restructuring and also cited adjusted second-quarter earnings of USD 1.08 per share against a USD 1.27 consensus estimate.

For investors, the contrast is clear: second-quarter recurring EBITDA improved sharply, but creditors are seeking fresh equity before the restructuring can advance. The market reaction on October 5, 2026 therefore sits alongside a financing process that still depends on agreement among Braskem's controlling holders and creditors.

Braskem stock gains 7.25 percent

Braskem stock was trading at EUR 0.74 at Lang & Schwarz on October 5, 2026 at 5:39 p.m. CEST, after the Xetra close. That was plus 7.25 percent versus the Lang & Schwarz prior close of EUR 0.69 on October 2, 2026.

Braskem stock facts

  • Company: Braskem S.A.
  • ISIN: BRBRKMACNPA4
  • WKN: 164640
  • Ticker: BAK
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 5, 2026, 5:39 p.m. CEST): EUR 0.74
  • Change versus prior close: plus 7.25 percent
  • Prior close Lang & Schwarz (October 2, 2026): EUR 0.69
  • Market capitalization: USD 655.5 million (as of October 5, 2026)
  • Sector / Industry: Basic Materials / Chemicals

More news and analyses on Braskem stock

Disclaimer...

en | BRBRKMACNPA4 | BAK | boerse | 70234458 | bgmi